OTC · VICP
Healthcare · Biotechnology
$0.55
Up+$0.00 (+0.00%)
Updated Oct 10, 2026, 3:21 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · VICP
1M range · 0 trading sessions · Daily adjusted prices
VICP does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning VICP.
Company
Market Activity
Research & News
VICP research
Company profile and research snapshot.
VICAPSYS LIFE SCIENCES
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 25, 2026
(OTC PINK:VICP) ("VICP" or the "Company") today announced the members of its Advisory Board, formed following the completion of the Company's reverse merger with of Puerto Rico, Inc. ("Stateline") on September 3, 2026.
Yahoo · Sep 23, 2026
(OTC PINK:VICP) ("VICP" or the "Company") today announced that it has completed its reverse merger with of Puerto Rico, Inc. ("Stateline"), effective September 3, 2026, and has entered into a definitive asset purchase agreement to acquire the FDA-approved NitroMist® (nitroglycerin) lingual aerosol product.
Yahoo · Sep 22, 2026
(OTC PINK:VICP) ("VICP" or the "Company") today announced that it has completed its reverse merger with of Puerto Rico, Inc. ("Stateline"), effective September 3, 2026, and has entered into a definitive asset purchase agreement to acquire the FDA-approved NitroMist® (nitroglycerin) lingual aerosol product.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VICP.
No results
No recent SID articles mention VICP.
